1. Reduced economic burden of AIDS-defining illnesses associated with adherence to antiretroviral therapy. (February 2020) Authors: Toh, Han-Siong; Yang, Chun-Ting; Yang, Kai-Li; Ku, Han-Chang; Liao, Chia-Te; Kuo, Shihchen; Tang, Hung-Jen; Ko, Wen-Chien; Ou, Huang-Tz; Ko, Nai-Ying Journal: International journal of infectious diseases Issue: Volume 91(2020) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial. (July 2018) Authors: Kuo, Shihchen; Ye, Wen; Duong, Justin; Herman, William H. Journal: Diabetes research and clinical practice Issue: Volume 141(2018) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population‐based, propensity‐score‐matched cohort study. Issue 2 (11th October 2018) Authors: Kuo, Shihchen; Yang, Chun‐Ting; Wu, Jin‐Shang; Ou, Huang‐Tz Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 2(2019) Page Start: 312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Early scale-up of antiretroviral therapy at diagnosis for reducing economic burden of cardiometabolic disease in HIV-infected population. (1st May 2020) Authors: Yang, Chun-Ting; Toh, Han-Siong; Liao, Chia-Te; Kuo, Shihchen; Ou, Huang-Tz; Ko, Nai-Ying Journal: AIDS Issue: Volume 34:Number 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. (January 2022) Authors: Sun, Hong; Saeedi, Pouya; Karuranga, Suvi; Pinkepank, Moritz; Ogurtsova, Katherine; Duncan, Bruce B.; Stein, Caroline; Basit, Abdul; Chan, Juliana C.N.; Mbanya, Jean Claude; Pavkov, Meda E.; Ramachandaran, Ambady; Wild, Sarah H.; James, Steven; Herman, William H.; Zhang, Ping; Bommer, Christian; ... Journal: Diabetes research and clinical practice Issue: Volume 183(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase‐4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients. Issue 3 (16th October 2020) Authors: Yang, Chen‐Yi; Lin, Wei‐Ann; Su, Pei‐Fang; Li, Lun‐Jie; Yang, Chun‐Ting; Ou, Huang‐Tz; Kuo, Shihchen Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 3(2021) Page Start: 772 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cost‐effectiveness of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model‐based simulation analysis using 10‐year real‐world data and targeted literature review. Issue 7 (26th April 2022) Authors: Peng, Zi‐Yang; Yang, Chun‐Ting; Ou, Huang‐Tz; Kuo, Shihchen Journal: Diabetes, obesity & metabolism Issue: Volume 24:Issue 7(2022) Page Start: 1328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge. (July 2022) Authors: Tew, Michelle; Willis, Michael; Asseburg, Christian; Bennett, Hayley; Brennan, Alan; Feenstra, Talitha; Gahn, James; Gray, Alastair; Heathcote, Laura; Herman, William H.; Isaman, Deanna; Kuo, Shihchen; Lamotte, Mark; Leal, José; McEwan, Phil; Nilsson, Andreas; Palmer, Andrew J.; Patel, Rishi; Pol... Journal: Medical decision making Issue: Volume 42:Number 5(2022) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Association of Renal and Cardiovascular Safety With DPP‐4 Inhibitors vs. Sulfonylureas in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease. Issue 2 (11th May 2021) Authors: Yang, Chun‐Ting; Lin, Wei‐Hung; Li, Lun‐Jie; Ou, Huang‐Tz; Kuo, Shihchen Journal: Clinical pharmacology & therapeutics Issue: Volume 110:Issue 2(2021) Page Start: 464 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cost‐effectiveness of long‐acting insulin analogues vs intermediate/long‐acting human insulin for type 1 diabetes: A population‐based cohort followed over 10 years. Issue 5 (23rd January 2020) Authors: Lee, Tsung‐Ying; Kuo, Shihchen; Yang, Chen‐Yi; Ou, Huang‐Tz Journal: British journal of clinical pharmacology Issue: Volume 86:Issue 5(2020) Page Start: 852 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗